Eiko Lifesciences Ltd — Important, 18-08-2026: Company Update

Eiko LifeSciences has allotted 305,000 equity shares following the conversion of an equal number of warrants. These shares were issued at Rs. 55 each, including a Rs. 45 premium, to promoter Bhavesh Dhirajlal Tanna and non-promoter V Square Pharmachem. The company received Rs. 1.26 Cr (representing 75% of the issue price) for these conversions. This increases the company's paid-up equity capital to Rs. 14.65 Cr, now comprising 14,650,854 shares. Around 2.65 million warrants remain outstanding, strengthening the company's capital base.